ENT & General Surgery

  • It is estimated that 2% to 5% of all patients who undergo surgery will develop a Surgical Site Infection (SSI). These infections are associated with added morbidity, including prolonged hospitalisation by 2 weeks, 5 times the risk of readmission, an increase in average health care costs of up to $26,000 per patient, and twice the risk of death.[1]
  • FloraSeal has been shown to trap and immobilise bacteria that may cause infection to the patient. It rapidly and powerfully kills gram-positive and gram-negative bacteria.[2]
  • FloraSeal effectively reduces microbial colonisation within 15 minutes and maintains a low microbial colonisation throughout the 24 hours after application, has the same efficacy when being used with or without an antimicrobial surgical incise drape, and mitigates microorganisms more effectively than an antimicrobial surgical incise drape alone.[3]

1. Towfigh, S., Cheadle, W. G., Lowry, S. F., Malangoni, M. A., & Wilson, S. E. (2008). Significant reduction in incidence of wound contamination by skin flora through use of microbial sealant. Archives of surgery (Chicago, Ill.:1960), 143(9), 885–891.

2. Prince, D., Kohan, K., Solanki, Z., Mastej, J., Prince, D., Varughese, R., & Patel, M. (2017). Immobilization and death of bacteria by Flora Seal microbial sealant. Int J Pharm Sci Invent, 6(6), 45-49.

3. Data on File. Adhezion Biomedical, LLC

SurgiSeal® Topical Skin Adhesive is a high purity, antimicrobial, liquid topical skin adhesive that can replace sutures for incision or laceration repair.

SurgiSeal® is the only topical skin adhesive in the world to receive FDA 510K Clearance in demonstrating inhibition of gram-positive and gram-negative bacteria growth.[1]

SurgiSeal® provides the optimal balance between strength and flexibility. In replacing sutures for incision or laceration repair, it can save time, provide a flexible, water-resistant, protective coating, and eliminate the need for suture removal.


1. SurgiSeal IFU: Due to the anhydrous property of the SurgiSeal adhesive, gram+ and gram- bacteria which become incorporated within the adhesive upon application, are not expected to grow.

  • Reduces blood loss and lowers transfusion rates during and after liver resections[4]
  • Reduces procedure time in hepatic transection[5]
  • Reduces postoperative pancreatic leaks following distal pancreatectomy[6]
  • Reduces blood loss and operative time for distal pancreatectomy[6]


  • Liver resection
  • Distal pancreatectomy
  • Partial nephrectomy

4. Geller DA, Tsung A, Maheshwari V et al. Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB 2005; 7:208-213.

5. Kaibori M, Matsui K, Ishizaki M, et al. A prospective randomized controlled trial of hemostasis with a bioplar sealer during hepatic transection for liver resection. Surgery 2013;154(5):1046-1052.

6. Blansfield JA, Rapp MM, Chokshi RJ et al. Novel method of stump closure for distal pancreatectomy with a 75% reduction in pancreatic fistula rate. J Gastrointest Surg 2012; 16(3):524-528.

  • PlasmaBlade™ has a significantly lower post-operative haemorrhage rate compared to Coblation[7]
  • The median total outpatient visit cost for tonsillectomy procedures with or without adenoidectomy was significantly lower with the PlasmaBlade™ compared to Coblation ($1,814 versus $2,050)[8]
  • Post-operative pain scores following adenotonsillectomy were significantly lower in the PlasmaBlade™ group compared to Coblation from post-operative days 7 to 11 and were equivalent between the two groups on all other post-operative days[9]
  • Coblation patients were 2.33 times more likely to experience minor bleeding events at home (that did not require medical intervention) compared to PlasmaBlade™ subjects[9]
  • Faster procedure times when compared to Coblation in adenotonsillectomy[10]
  • Unimpeded performance in wet and dry surgical fields eliminates the need for instrument exchanges, thereby simplifying surgical procedures[11]


  • Tonsillectomy
  • Adenoidectomy
  • Uvulopalatopharyngoplasty (UPPP)
  • Patients with pacemaker, DBS, or spine stimulator insitu

7. Lane JC, Dworkin-Valenti J, Chiodo L, Haupert M. Postoperative tonsillectomy bleeding complications in children: A comparison of three surgical techniques. International Journal of Pediatric Otorhinolaryngology. 2016; 88:184-188.

8. Internal Study Report. A propensity score matched study of PlasmaBlade vs Coblation technology during pediatric tonsillectomy and adenoidectomy procedures. 66-20-0008.

9. Spektor Z, Kay DJ, Archilla A, Mandell DL. Prospective Comparative Study of PEAK and Coblation Pediatric Tonsillectomy and Adenoidectomy. Presentated at Society for Ear, Noseand Throat Advances in Children (SENTAC); San Antonio, TX December 4th, 2015.

10. Thottam PJ, Christenson JR, Cohen DS, Metz CM, Saraiya SS, Haupert MS. The utility of common surgical instruments for pediatric adenotonsillectomy. Laryngoscope.2015;125(2):475-479.

11. Palanker DV, Vankov A, Huie P. Electrosurgery with cellular precision. IEEE Trans Biomed Eng. 2008;55(2 Pt 2):838-841.

  • The RadiaLux™ lighted retractor is a single-use retractor designed to provide surgeons with the ability to manipulate soft tissue through a combination of blades when assembled onto a retractor handle.
  • The retractor provides illumination to the surgical field independent of an external light source or fibre optic cables.
  • The lighted retractor is indicated for enhancing visibility to a surgical field through retraction of soft tissue and illumination of the surgical cavity.

Revolution Surgical Pty Ltd
5/14-16 Crescent Street, Rozelle NSW 2039 AU
ABN: 63 165 643 434

© 2018-2024 Revolution Surgical

Website by: WebInjection